NL-OMON27532招募中不适用
Immune phenotyping in chronic hepatitis C patients treated with Sofosbuvir and Daclatasvir combination with or without Ribavirin for 12 or 24 weeks -SODA study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- AMC
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects infected with HCV genotype 1, 3 or 4.
- •- Subjects who are treatment-naïve to or relapsed after any previous antiviral therapy other than combination of sofosbuvir + NS5A inhibitor ± ribavirin
- •- Age: 18 - 65 years
- •- Males, or post-menopausal or hysterectomized females
排除标准
- •- Women of childbearing potential
- •- Other known cause of liver disease except for CHC
研究者
相似试验
进行中（未招募）
1 期
A study looking at the immune response in chronic hepatitis C patients treated with Sofosbuvir and Daclatasvir combination with or without Ribavirin for 12 or 24 weeks.Chronic hepatitis CEUCTR2014-002808-25-NLAcademic Medical Center Amsterdam
已完成
3 期
Immune phenotyping in chronic HCV patients treated with Sofosbuvir and Daclatasvir combination for 12 or 24 weeks * SODA studyChronic hepatitis C1001965410047438Hepatitis CNL-OMON44573Academisch Medisch Centrum32
已完成
不适用
Impact of Immune Responses in Chronic Hepatitis C Genotype 1 Virus Infected Patients during Treatment with Peg-Interferon-alpha-2b and Ribavirin.NL-OMON30088Foundation for Liver Research (SLO)20
已完成
4 期
CHESS - Curing Hepatitis C: Effect on the Endothelium and cardiovaScular riSk - a pilot single arm trial, assessing the effect of hepatitis C virus (HCV) treatment with 12 weeks of paritaprevir/ritonavir/ombitasvir, dasabuvir +/- ribavirin on endothelial function.Hepatitis C virus infectionEndothelial functionInfection - Other infectious diseasesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615001167550John Hunter Hospital16
已完成
2 期
THE HEP573 STUDY: A randomised, double-blind, placebo-controlled clinical trial of silymarin alone, and silymarin combined with antioxidants in chronic hepatitis CChronic Hepatitis CAlternative and Complementary Medicine - Herbal remediesAlternative and Complementary Medicine - Other alternative and complementary medicineOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12614000966695John Hunter Hospital216